Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heidelore Hofmann

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
The Journal of Investigative Dermatology|February 27, 2003
Laboratory acquired infection with recombinant vaccinia virus containing an immunomodulating constructMartin Mempel, Gisela Isa, Norbert Klugbauer, et al.
The Journal of Investigative Dermatology|July 11, 2008
Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22Kilian Eyerich, Stefanie Foerster, Stephanie Rombold, et al.
European Journal of Immunology|March 5, 2003
Artificial-infection protocols allow immunodetection of novel Borrelia burgdorferi antigens suitable as vaccine candidates against Lyme diseaseReinhard Wallich, Oliver Jahraus, Thomas Stehle, et al.
German Medical Science : GMS E-Journal|November 6, 2025
Guidelines for diagnosis and treatment in neurology - Lyme neuroborreliosisSebastian Rauer, Stefan Kastenbauer, Rick Dersch, et al.
Advances in Radiation Oncology|October 30, 2018
Superficial radiation therapy in peyronie's disease: An effective and well-tolerated therapyGunilla Pietsch, Tobias Anzeneder, Harald Bruckbauer, et al.
German Medical Science : GMS E-Journal|April 29, 2020
Guidelines for diagnosis and treatment in neurology - Lyme neuroborreliosisSebastian Rauer, Stephan Kastenbauer, Heidelore Hofmann, et al.
International Journal of Medical Microbiology : IJMM|July 10, 2007
Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. novVolker Fingerle, Ulrike C Schulte-Spechtel, Eva Ruzic-Sabljic, et al.
International Archives of Allergy and Immunology|May 13, 2006
Modulation of atopy patch test and skin prick test by pretreatment with 1% pimecrolimus creamStephanie Weissenbacher, Claudia Traidl-Hoffmann, Kilian Eyerich, et al.
Diagnostic Microbiology and Infectious Disease|December 21, 2002
Multicenter comparison of Fungitest for susceptibility testing of Candida speciesBirgit Willinger, Elisabeth Engelmann, Heidelore Hofmann, et al.
Systematic Reviews|May 5, 2016
Efficacy and safety of pharmacological agents in the treatment of erythema migrans in early Lyme borreliosis-systematic review protocolGabriel Torbahn, Heidelore Hofmann, Roman Allert, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
The Journal of Investigative Dermatology|February 27, 2003
Laboratory acquired infection with recombinant vaccinia virus containing an immunomodulating constructMartin Mempel, Gisela Isa, Norbert Klugbauer, et al.
The Journal of Investigative Dermatology|July 11, 2008
Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22Kilian Eyerich, Stefanie Foerster, Stephanie Rombold, et al.
European Journal of Immunology|March 5, 2003
Artificial-infection protocols allow immunodetection of novel Borrelia burgdorferi antigens suitable as vaccine candidates against Lyme diseaseReinhard Wallich, Oliver Jahraus, Thomas Stehle, et al.
German Medical Science : GMS E-Journal|November 6, 2025
Guidelines for diagnosis and treatment in neurology - Lyme neuroborreliosisSebastian Rauer, Stefan Kastenbauer, Rick Dersch, et al.
Advances in Radiation Oncology|October 30, 2018
Superficial radiation therapy in peyronie's disease: An effective and well-tolerated therapyGunilla Pietsch, Tobias Anzeneder, Harald Bruckbauer, et al.
German Medical Science : GMS E-Journal|April 29, 2020
Guidelines for diagnosis and treatment in neurology - Lyme neuroborreliosisSebastian Rauer, Stephan Kastenbauer, Heidelore Hofmann, et al.
International Journal of Medical Microbiology : IJMM|July 10, 2007
Epidemiological aspects and molecular characterization of Borrelia burgdorferi s.l. from southern Germany with special respect to the new species Borrelia spielmanii sp. novVolker Fingerle, Ulrike C Schulte-Spechtel, Eva Ruzic-Sabljic, et al.
International Archives of Allergy and Immunology|May 13, 2006
Modulation of atopy patch test and skin prick test by pretreatment with 1% pimecrolimus creamStephanie Weissenbacher, Claudia Traidl-Hoffmann, Kilian Eyerich, et al.
Diagnostic Microbiology and Infectious Disease|December 21, 2002
Multicenter comparison of Fungitest for susceptibility testing of Candida speciesBirgit Willinger, Elisabeth Engelmann, Heidelore Hofmann, et al.
Systematic Reviews|May 5, 2016
Efficacy and safety of pharmacological agents in the treatment of erythema migrans in early Lyme borreliosis-systematic review protocolGabriel Torbahn, Heidelore Hofmann, Roman Allert, et al.
Pageof 4